Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc

<< Previous

Bullboard Posts

Next >>

Post by kiskadogon Nov 25, 2015 11:35am

110 Views

Post# 24324134

BUYS better than SELLS

Always good to see NPC insiders BUYING vs SELLING.

As of 11:59pm ET November 24th, 2015 Filing
Date Transaction
Date Insider Name Ownership
Type Securities Nature of transaction Volume or Value Price Nov 13/15 Nov 11/15 Tremblay, Denis Direct Ownership Common Shares 10 - Acquisition in the public market 26,000 $0.750
Nov 13/15 Nov 10/15 Filion, Yves Direct Ownership Common Shares 10 - Acquisition in the public market 40,000 $0.750
Nov 11/15 Nov 10/15 Rochette, Jean Direct Ownership Common Shares 10 - Acquisition in the public market 15,000 $0.742
Nov 11/15 Nov 10/15 Rochette, Jean Direct Ownership Common Shares 10 - Acquisition in the public market 16,000 $0.745
Nov 11/15 Nov 10/15 Reny, Luc Direct Ownership Common Shares 10 - Acquisition in the public market 30,000 $0.741 - See more at: https://www.canadianinsider.com/company?menu_tickersearch=NPC%20%7C%20NAPEC#sthash.scyezcTN.dpuf

https://www.canadianinsider.com/company?menu_tickersearch=NPC%20|%20NAPEC